Libo Wang

发表

Exploring Key Genes to Construct a Diagnosis Model of Dilated Cardiomyopathy

Chunguang Qiu, Qin Dang, Siyuan Weng, 2022, Frontiers in Cardiovascular Medicine.

Engineering neoantigen vaccines to improve cancer personalized immunotherapy

Huanyu Li, Y. Kong, Qin Dang, 2022, International journal of biological sciences.

Machine learning algorithm-generated and multi-center validated melanoma prognostic signature with inspiration for treatment management

Jian Zhang, P. Luo, Qin Dang, 2022, Cancer Immunology, Immunotherapy.

Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment

Jianzhuang Ren, C. Cao, Siyuan Weng, 2022, Frontiers in Immunology.

Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer

Jun Yu Li, R. Zhu, Yuling Sun, 2022, bioRxiv.

BEST: a web application for comprehensive biomarker exploration on large-scale data in solid tumors

Q. Cheng, Jian Zhang, Lifeng Li, 2022, bioRxiv.

Ferroptosis: a double-edged sword mediating immune tolerance of cancer

Qin Dang, Zaoqu Liu, Xinwei Han, 2022, Cell Death & Disease.

SurvivalML: an integrative platform for the discovery and exploration of prognostic models in multi-center cancer cohorts

Q. Cheng, Jian Zhang, P. Luo, 2022, bioRxiv.

The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma

Xinwei Han, D. Jiao, Yuling Sun, 2021, Frontiers in Oncology.

Establishment and experimental validation of an immune miRNA signature for assessing prognosis and immune landscape of patients with colorectal cancer

Yanli Wang, Xinwei Han, D. Jiao, 2021, Journal of cellular and molecular medicine.

Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer

D. Jiao, Zhenqiang Sun, Jing Li, 2021, Frontiers in Immunology.

Machine learning algorithm-generated and multi-center validated melanoma prognostic signature with inspiration for treatment management

Jian Zhang, P. Luo, Qin Dang, 2022, Cancer Immunology, Immunotherapy.

Multi-omics landscape and clinical significance of a SMAD4-driven immune signature: Implications for risk stratification and frontline therapies in pancreatic cancer

Jun Yu Li, R. Zhu, Yuling Sun, 2022, Computational and structural biotechnology journal.

Association of RYR2 Mutation With Tumor Mutation Burden, Prognosis, and Antitumor Immunity in Patients With Esophageal Adenocarcinoma

Xinwei Han, D. Jiao, Zhenqiang Sun, 2021, Frontiers in Genetics.

Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer

Zhenqiang Sun, Qin Dang, Siyuan Weng, 2022, Nature Communications.

Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer

Zhenqiang Sun, Qin Dang, Siyuan Weng, 2022, Nature Communications.

Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer

Hui Xu, Zhenqiang Sun, Chunguang Guo, 2021, EBioMedicine.

Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer

Xinwei Han, D. Jiao, Zhenqiang Sun, 2021, Cancer Cell International.

Integrated Analysis of Multi-Omics Alteration, Immune Profile, and Pharmacological Landscape of Pyroptosis-Derived lncRNA Pairs in Gastric Cancer

Yin Yu, Z. Hua, Siyuan Weng, 2022, Frontiers in Cell and Developmental Biology.

Molecular Characterization and Clinical Relevance of ALDH2 in Human Cancers

Lifeng Li, Lingfang Meng, Tao Huang, 2022, Frontiers in Medicine.

PI3K pathway mutation predicts an activated immune microenvironment and better immunotherapeutic efficacy in head and neck squamous cell carcinoma

Q. Cheng, Jian Zhang, P. Luo, 2023, World Journal of Surgical Oncology.

Exploring the roles of intestinal flora in enhanced recovery after surgery

Na Li, Qin Dang, Zaoqu Liu, 2023, iScience.

Comprehensive Molecular Analyses of a Novel Mutational Signature Classification System with Regard to Prognosis, Genomic Alterations, and Immune Landscape in Glioma

Xinwei Han, Lifeng Li, Zaoqu Liu, 2021, Frontiers in Molecular Biosciences.

EGR1 and KLF4 as Diagnostic Markers for Abdominal Aortic Aneurysm and Associated With Immune Infiltration

Zhen Li, Yin Yu, Qin Dang, 2022, Frontiers in Cardiovascular Medicine.

Development and Validation of Ischemic Events Related Signature After Carotid Endarterectomy

Can Cao, Yin Yu, Z. Hua, 2022, Frontiers in Cell and Developmental Biology.

Epigenetically regulated gene expression profiles decipher four molecular subtypes with prognostic and therapeutic implications in gastric cancer

Jinhai Deng, Siyuan Weng, Hui-Xian Xu, 2023, Clinical Epigenetics.

Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma

Hui Xu, Chunguang Guo, Siyuan Weng, 2021, Frontiers in Oncology.

Immunosenescence: molecular mechanisms and diseases

Q. Cheng, Yi Zhang, Yi Zhang, 2023, Signal transduction and targeted therapy.

CELF2 is a candidate prognostic and immunotherapy biomarker in triple‐negative breast cancer and lung squamous cell carcinoma: A pan‐cancer analysis

Jie Zhao, D. Jiao, Lifeng Li, 2021, Journal of cellular and molecular medicine.

Comparison of Three Prediction Rules for Assessing the Risk of Gastric Cancer in Chinese Health Examination Populations

P. Xu, Xiao-Xi Xie, Jing Wang, 2021 .

Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical Management

Xinwei Han, D. Jiao, Zhaonan Li, 2021, Journal of oncology.

Comprehensive Molecular Analyses of a Six-Gene Signature for Predicting Late Recurrence of Hepatocellular Carcinoma

Xinwei Han, Zhen Li, Xin Li, 2021, Frontiers in Oncology.

Multi-center validation of an immune-related lncRNA signature for predicting survival and immune status of patients with renal cell carcinoma: an integrating machine learning-derived study

Siyuan Weng, Hui-Xian Xu, C-C Guo, 2023, Journal of Cancer Research and Clinical Oncology.

Genome-scale CRISPR-Cas9 screening stratifies pancreatic cancer with distinct outcomes and immunotherapeutic efficacy.

Siyuan Weng, Hui-Xian Xu, C-C Guo, 2023, Cellular signalling.

TTN/OBSCN ‘Double‐Hit’ predicts favourable prognosis, ‘immune‐hot’ subtype and potentially better immunotherapeutic efficacy in colorectal cancer

Xinwei Han, D. Jiao, Zhenqiang Sun, 2021, Journal of cellular and molecular medicine.

A tumor-infiltrating immune cells-related pseudogenes signature based on machine-learning predicts outcomes and immunotherapy responses in ovarian cancer.

Jian Zhang, P. Luo, Siyuan Weng, 2023, Cellular signalling.

Immune perturbation network identifies an EMT subtype with chromosomal instability and tumor immune-desert microenvironment

Ke Chen, Siyuan Weng, Hui-Xian Xu, 2023, iScience.

Crosstalk of cell death pathways unveils an autophagy-related gene AOC3 as a critical prognostic marker in colorectal cancer

Siyuan Weng, Hui-Xian Xu, Zaoqu Liu, 2024, Communications biology.

Associations Between Life's Essential 8 and Chronic Kidney Disease

Hui-Xian Xu, C-C Guo, Zaoqu Liu, 2023, Journal of the American Heart Association.